Anna Bustin, PharmD, BCPPS
Anna Bustin

Anna Bustin, PharmD, BCPPS

Anna Bustin, PharmD, BCPPS, is a residency preceptor with the Pharmacy Residency Program and a clinical pharmacy specialist in Neonatal / Infant Intensive Care at Children's Hospital of Philadelphia.

Areas of expertise: Neonatology, Parenteral nutrition, Pulmonary hypertension, Bronchopulmonary dysplasia, Chronic lung disease

Locations: Main Building

About Anna Bustin, PharmD, BCPPS

Titles

Clinical Pharmacy Specialist, Neonatal / Infant Intensive Care

Certifications

Basic Life Support (BLS)

Board Certified Pediatric Pharmacy Specialist (BCPPS)

Pediatric Advanced Life Support (PALS)

Pharmacy-Based Immunization Certification

Leadership and Memberships

Memberships in Professional Organizations

Pediatric Pharmacy Association (PPA)

Research Interests

Diazoxide induced pulmonary hypertension IV compatibility Neonatal status epilepticus Hypoxic ischemic encephalopathy Parenteral nutrition Diuretic therapy in BPD

Education & training

Undergraduate Degree

BS in Nutrition, University of Tennessee, Knoxville, TN

Graduate Degree

PharmD - Lipscomb University College of Pharmacy, Nashville, TN

Residency

Pharmacy Practice (PGY 1) - Children’s Hospital of Philadelphia, Philadelphia, PA
Pediatric Specialty (PGY 2) - Children’s Hospital of Philadelphia, Philadelphia, PA

Team affiliations

 View fewer all team affiliations View all all team affiliations

Publications

Publications

2024

Grossman M, Bustin A, Ellis K, et al.  Optimizing Therapeutic Enoxaparin in Preterm Neonates and Infants.  J Perinatol.  Manuscript submitted for publication.

Nelin TD, Huber M, Jensen EA, et al.  Association of furosemide versus chlorothiazide exposures and serum sodium, potassium, and chloride among infants with bronchopulmonary dysplasia.  J Perinatol.  Manuscript submitted for publication.

Zierk A, Gumbel MJ, Mackenzie R, et al.  A Quality Improvement Initiative to Reduce Excess Inhaled Therapy Use in the Neonatal Intensive Care Unit.   J Perinatol.  Manuscript submitted for publication.

2022

Serio J, Gattoline S, Collier H, Bustin A. Evaluation of sirolimus dosing in neonates and infants with lymphatic disorders.  J Pediatr Pharmacol Ther. J Pediatr Pharmacol Ther. 2022;27(5):447-458.

McElroy NA, Bustin A, Gattoline S.  Evaluation of the Safety of Ketorolac in Postsurgical Infants Less than Six Months of Age.  J Pediatr Pharmacol Ther. J Pediatr Pharmacol Ther. 2022;27(4):347–351

2021

Sanseau E, et al.  Pediatric Emergency Medicine Simulation Curriculum: Vitamin K Deficiency in the Newborn. MedEdPORTAL. 2021;17:11078

2020

Bustin A, Ramsey EZ, Hanna BD, Kaushal G. Compatibility of treprostinil sodium and dopamine hydrochloride during Y-site administration. Am J Health-Syst Pharm. 2020;77:649-657